All In Biotech

Drug Trial Radar · NCT07685600

Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants

An Open-label, Randomised, Two Arm, Fixed Sequence Study in Healthy Participants to Assess the Pharmacokinetics of AZD4144 When Administered Alone and in Combination With Itraconazole

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Jul 30, 2026

Primary completion

Oct 22, 2026

Study completion Oct 22, 2026

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jul 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.

Conditions

  • Healthy

Interventions

  • AZD4144Drug

    AZD4144 will be administered orally.

  • AZD4144Drug

    AZD4144 will be administered as an IV infusion.

  • ItraconazoleDrug

    Itraconazole will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under concentration time curve from time 0 to infinity (AUCinf)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16
  2. Area under concentration curve from time 0 to the last quantifiable concentration (AUClast)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16
  3. Maximum observed drug concentration (Cmax)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Harrow, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.